Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Apollo to get an investment worth $150m from KIC
South Korea’s sovereign wealth fund, Korea Investment Corporation (KIC), is set to invest $150m in Apollo Global Management, the world’s second-largest private equity firm. As global funds seek alternative markets for investments and fundraising due to restrictions in...
KKR Completes ~$240m Investment in Reliance Retail
Reliance Retail Ventures Ltd, the retail arm of Reliance Industries, has received the full subscription amount of $240m from the global investment firm KKR and has allotted 17.1m equity shares. Following the share allotment, KKR's shareholding in Reliance Retail...
EQT-backed Lima to be acquired for $850m by Enovis
Lima is controlled by private equity firm EQT AB. Enovis Corp, a U.S. maker of orthopedic bracing and shoe inserts, has agreed to acquire Italian surgical implant manufacturer LimaCorporate SpA for approximately $850m, including debt, according to people familiar with...